FSP Integrated Solutions

Clinical development and post-approval lifecycle management demand flexibility. Parexel’s FSP Integrated Solutions helps you adapt to changing portfolio needs through tailored delivery models, specialized expertise and technology-enabled execution that provide access to the right capabilities, when and where you need them.

Let's start a conversation

Our FSP delivery model is designed for high performance on day one to power ongoing, trusted relationships

Every program requires a different balance of scale, speed and specialization. That's why our FSP Integrated Solutions is designed to scale with your portfolio, enhance productivity through people, processes, technology and ParexelAI™, and provide the specialized expertise needed when and where it matters most.

 

Parexel FSP Integrated Solutions.png


 

Leading through change, together.

As portfolio priorities shift, organizations need new ways to access expertise, scale capabilities and improve productivity without increasing organizational complexity. 

Increasingly, sponsors are looking beyond traditional resourcing models, to flexible partnerships that can evolve alongside their pipeline and business priorities. 

In this video, Parexel leaders Rob Goodwin and Sanjay Vyas share their perspectives on what sponsors need most from partners today and how meaningful collaboration can help organizations navigate change with confidence. Together, they explore how aligning expertise, technology and operational excellence around a shared purpose can accelerate progress and help bring innovative therapies to patients faster.

Advantages

Adapt as you go

Priorities rarely stay the same. That's why we work with you to build a flexible solution that evolves alongside your pipeline. Whether you need additional capacity, specialized expertise or an integrated delivery model, we help you scale resources, accelerate execution and maintain control across the development and post-approval lifecycle.


Global talent, on demand

Access the expertise you need, when and where you need it. Through our global talent ecosystem, regional delivery hubs and dedicated recruiting capabilities, we help you quickly connect with skilled professionals across clinical development to support changing program needs.


Built around you

Whether you're augmenting an existing team, building a functional capability or combining FSP and full-service delivery, we partner with you to create a flexible operating model that helps you deploy and scale capabilities as portfolio needs evolve.


Expertise that delivers

Bring the right expertise to every stage of development. From clinical operations and biometrics to regulatory, safety, medical writing and therapeutic expertise, our teams help you maintain quality, continuity, and momentum across complex programs.


Technology that accelerates

Gain access to innovation, technology and AI-enabled capabilities that are continuously evolving through Parexel's ongoing investments in productivity and performance.


Scale without limits

Expand globally without sacrificing quality or oversight. Our worldwide infrastructure, governance frameworks and operational support help you scale efficiently while maintaining consistency, compliance and performance.

Clinical operations

From study start-up to quality assurance and risk management, our clinical operations personnel (CRAs, study managers, start-up specialists, operations managers and data managers) provide flexible and customized solutions to meet your specific needs while ensuring high-quality clinical trial execution.

You'll benefit from flexible resource allocation, improved cost-efficiency, enhanced quality, and accelerated timelines. We deliver tailored solutions that are aligned with your unique needs.

Our clinical operations personnel can complement your internal expertise or handle all operational aspects of your studies.

Data management

Our data operations experts efficiently and accurately manage clinical trial data throughout its lifecycle. This includes data collection, processing, validation, analysis and reporting. The team ensures that data is captured in a standardized and reliable manner, adhering to regulatory requirements and industry best practices.

The data operations team collaborates closely with sponsors, clinical operations teams and other stakeholders to develop data management plans, establish data standards and implement data capture strategies. They are responsible for setting up electronic data capture systems, developing data validation checks and cleaning the data to ensure its quality and integrity.

Medical writing

Our medical writing team works closely with you to create high-quality, well-structured and scientifically accurate documents that support your clinical development and regulatory strategies.

Our team includes roles such as associate medical writers, senior medical writers, document quality reviewer, principal document quality reviewer, document specialist, lead document specialist and medical writing support coordinator. 

This collective team handles everything from document writing and preparation for product development, approval and commercialization to authoring, medical writing project management, trial disclosure and publishing.

Regulatory

Our global regulatory colleagues (including regulatory affairs managers, compliance experts and project managers) provide expertise across a range of outsourced regulatory solutions, including regulatory dossier compilation, publishing and dispatch, clinical trial applications, centralized CMC and labelling and post-approval submissions and lifecycle management. We also partner with clients on project-based deliverables including regulatory strategy, market authorization submissions, M&A license transfers and RIM – data entry, data cleansing and data migration. 

We work with clients on asset-based outsourcing, often for mature products or low-risk portfolios or on a functional basis for activities like CMC, labeling or publishing. Services are delivered by a unitized (deliverable) model, or an FSP (dedicated FTE) model.

By outsourcing and consolidating non-core regulatory activities, our experts can ensure your regulatory team focuses on core business activities and your development pipeline.

Pharmacovigilance

Our pharmacovigilance function serves to ensure the safety and well-being of patients participating in clinical trials. Our PV team is responsible for the efficient collection, evaluation, and reporting of adverse events and other safety-related information to the relevant regulatory authorities. We comply with global regulatory guidelines and industry standards to ensure the highest level of patient protection.

Through close collaboration with our FSP partners, we establish and maintain robust safety management plans, develop standard operating procedures, and conduct thorough safety trainings.

Translational medicine

Our translational medicine group – comprised of scientific directors, biomarker sample management specialists, biomarker sample operations associates and precision medicine associate directors – conceives and implements data-driven, target therapy development strategies to deliver novel therapies that treat patients based on their unique genomic and biomarker characteristics. Our genomic medicine scientists apply expertise, innovation and state-of-the-art methodologies in the strategic and operational implementation of genomics and biomarker services to help clients:

  • Better understand the genetic/genomic basis for the disease, drug, target and pathway
  • Differentiate drugs from competitor medicines in development or on the market
  • Stratify drug responders/non-responders and enrich clinical trial design
  • Develop biomarker and companion diagnostics strategies
  • Inform the benefit-risk profile of personalized medicine

Case Study

Strategic FSP model transformation

A top five biopharmaceutical company set out to transform its clinical development operating model, transitioning from a predominantly full-service outsourcing (FSO) approach to a strategic FSP model. The goal was to increase agility, improve resource efficiency and strengthen operational consistency across a global portfolio of more than 75 studies spanning four continents and 41 countries.

  • The transformation required a significant reorganization of global clinical operations, including the recruitment and deployment of more than 580 clinical operations professionals.
  • To support evolving portfolio priorities, the sponsor redefined roles, reallocated resources and introduced a new FSP operating model. Parexel was selected as one of two strategic partners to help design and implement the transformation.
Situation

A top five biopharmaceutical company set out to transform its clinical development operating model, transitioning from a predominantly full-service outsourcing (FSO) approach to a strategic FSP model. The goal was to increase agility, improve resource efficiency and strengthen operational consistency across a global portfolio of more than 75 studies spanning four continents and 41 countries.

  • The transformation required a significant reorganization of global clinical operations, including the recruitment and deployment of more than 580 clinical operations professionals.
  • To support evolving portfolio priorities, the sponsor redefined roles, reallocated resources and introduced a new FSP operating model. Parexel was selected as one of two strategic partners to help design and implement the transformation.

FAQs

FSP stands for Functional Service Provider in clinical research. It is a model in which a company outsources specific functional activities or services to a third-party service provider. FSPs work closely with the sponsor organization to provide specialized expertise, resources, and operational support in areas such as data management, biostatistics, clinical monitoring, drug safety, and regulatory affairs. By engaging an FSP, sponsors can enhance efficiency, flexibility, and cost-effectiveness in delivering clinical trials.

FSO stands for Functional Service Outsourcing, while FSP stands for Functional Service Provider. Both FSO and FSP are models commonly used in the pharmaceutical and clinical research industry to support specific functions or services required in a clinical trial.

FSO refers to the outsourcing of specific functions or activities to an external service provider. In an FSO model, the service provider takes ownership of the entire function and provides all the necessary resources, infrastructure, and expertise to perform the activities. For example, a company may outsource its clinical data management function to an FSO provider.

On the other hand, FSP refers to the engagement of an external service provider to provide specific expertise or resources while working in collaboration with the internal team. In an FSP model, the service provider works as an extension of the internal team, focusing on providing the required expertise or resources for a specific function. For example, a company may engage an FSP provider to provide biostatistics support for a particular clinical trial.

Getting started with Parexel

Stay current with novel thinking and actionable insights from our experts.

Having trouble with the form? Open it in a new tab.